Literature DB >> 9640196

Adhesion molecules in iris biopsy specimens from patients with uveitis.

E La Heij1, R W Kuijpers, S G Baarsma, A Kijlstra, M van der Weiden, C M Mooy.   

Abstract

BACKGROUND/AIMS: Earlier studies on intraocular tissue have demonstrated that T lymphocytes play a major role in the pathogenesis of uveitis. Adhesion molecules are immunoregulatory molecules for the interaction between T lymphocytes and vascular endothelium and they play an important role in the recruitment of specific T lymphocytes from the circulation into inflamed tissue. In uveitis an increased expression of some of these adhesion molecules may be expected.
METHODS: The presence of adhesion molecules was investigated in iris biopsy specimens from 11 patients with uveitis and eight controls (patients with primary open angle glaucoma) immunohistochemically with a panel of monoclonal antibodies: LECAM (CD 62L), ICAM-1 (CD 54), LFA-1 (CD 11a/18), VCAM-1 (CD 106), VLA-4 (CD 49d), and HECA-452, a marker for high endothelial venules.
RESULTS: Positive staining for ICAM-1, LFA-1 and VCAM-1 was found in the iris in a significantly higher number of uveitis patients than in controls. The remaining adhesion molecules were also found in a higher number of uveitis patients than in controls, but this difference did not reach statistical significance.
CONCLUSION: An increased expression of adhesion molecules was found in the iris of patients with uveitis, indicating an immunoregulatory function for adhesion molecules in the pathogenesis of uveitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9640196      PMCID: PMC1722550          DOI: 10.1136/bjo.82.4.432

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  22 in total

1.  Expression of cell adhesion molecules in posterior uveitis.

Authors:  S M Whitcup; C C Chan; Q Li; R B Nussenblatt
Journal:  Arch Ophthalmol       Date:  1992-05

2.  Immune deposits in iris biopsy specimens from patients with Fuchs' heterochromic iridocyclitis.

Authors:  E La Hey; C M Mooy; G S Baarsma; J de Vries; P T de Jong; A Kijlstra
Journal:  Am J Ophthalmol       Date:  1992-01-15       Impact factor: 5.258

Review 3.  Leukocyte-endothelial adhesion molecules.

Authors:  T M Carlos; J M Harlan
Journal:  Blood       Date:  1994-10-01       Impact factor: 22.113

Review 4.  Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm.

Authors:  T A Springer
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

5.  Immunohistochemical analysis of iris biopsy specimens from patients with Fuchs' heterochromic cyclitis.

Authors:  P I Murray; C M Mooy; E Visser-de Jong; G S Baarsma; P T de Vries; V M de Jong; A Kijlstra
Journal:  Am J Ophthalmol       Date:  1990-04-15       Impact factor: 5.258

6.  Monoclonal antibodies against ICAM-1 (CD54) and LFA-1 (CD11a/CD18) inhibit experimental autoimmune uveitis.

Authors:  S M Whitcup; L R DeBarge; R R Caspi; R Harning; R B Nussenblatt; C C Chan
Journal:  Clin Immunol Immunopathol       Date:  1993-05

7.  Identification of the lymphokines, interferon-gamma and interleukin-2, in inflammatory eye diseases.

Authors:  J J Hooks; C C Chan; B Detrick
Journal:  Invest Ophthalmol Vis Sci       Date:  1988-09       Impact factor: 4.799

8.  Distribution of lymphocytes and cell adhesion molecules in iris biopsy specimens from patients with uveitis.

Authors:  D Wakefield; P McCluskey; P Palladinetti
Journal:  Arch Ophthalmol       Date:  1992-01

9.  Efficacy of antibodies to adhesion molecules, CD11a or CD18, in rabbit models of uveitis.

Authors:  J T Rosenbaum; R S Boney
Journal:  Curr Eye Res       Date:  1993-09       Impact factor: 2.424

10.  Low mature TGF-beta 2 levels in aqueous humor during uveitis.

Authors:  J H de Boer; J Limpens; S Orengo-Nania; P T de Jong; E La Heij; A Kijlstra
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-09       Impact factor: 4.799

View more
  7 in total

Review 1.  Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease.

Authors:  Arnd Heiligenhaus; Stephan Thurau; Maren Hennig; Rafael S Grajewski; Gerhild Wildner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-25       Impact factor: 3.117

2.  Effects of the immunomodulator, VGX-1027, in endotoxin-induced uveitis in Lewis rats.

Authors:  K Mangano; N Y Sardesai; C Quattrocchi; E Mazzon; S Cuzzocrea; K Bendtzen; P L Meroni; J J Kim; F Nicoletti
Journal:  Br J Pharmacol       Date:  2008-09-08       Impact factor: 8.739

3.  Therapeutic targeting of STAT3 (signal transducers and activators of transcription 3) pathway inhibits experimental autoimmune uveitis.

Authors:  Cheng-Rong Yu; Yun Sang Lee; Rashid M Mahdi; Narayanan Surendran; Charles E Egwuagu
Journal:  PLoS One       Date:  2012-01-05       Impact factor: 3.240

4.  Genetic polymorphisms of cell adhesion molecules in Behcet's disease in a Chinese Han population.

Authors:  Minming Zheng; Lijun Zhang; Hongsong Yu; Jiayue Hu; Qingfeng Cao; Guo Huang; Yang Huang; Gangxiang Yuan; Aize Kijlstra; Peizeng Yang
Journal:  Sci Rep       Date:  2016-04-25       Impact factor: 4.379

Review 5.  Adhesion Molecule Targeted Therapy for Non-Infectious Uveitis.

Authors:  Yi-Hsing Chen; Sue Lightman; Malihe Eskandarpour; Virginia L Calder
Journal:  Int J Mol Sci       Date:  2022-01-03       Impact factor: 5.923

6.  Combined Therapeutics for Atherosclerosis Treatment Using Polymeric Nanovectors.

Authors:  Baltazar Hiram Leal; Brenda Velasco; Adriana Cambón; Alberto Pardo; Javier Fernandez-Vega; Lilia Arellano; Abeer Al-Modlej; Víctor X Mosquera; Alberto Bouzas; Gerardo Prieto; Silvia Barbosa; Pablo Taboada
Journal:  Pharmaceutics       Date:  2022-01-22       Impact factor: 6.321

7.  Aqueous humour cytokines profiles in eyes with Coats disease and the association with the severity of the disease.

Authors:  Tingyi Liang; Yu Xu; Xiuyu Zhu; Xiang Zhang; Jing Li; Peiquan Zhao
Journal:  BMC Ophthalmol       Date:  2020-05-05       Impact factor: 2.209

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.